Wang Luhua 4
4 · Summit Therapeutics Inc. · Filed Mar 2, 2021
Insider Transaction Report
Form 4
Wang Luhua
Director
Transactions
- Award
Stock Option (right to buy)
2021-02-26$6.77/sh+70,000$473,900→ 70,000 totalExercise: $6.77Exp: 2031-02-26→ Common Stock (70,000 underlying) - Award
Stock Option (right to buy)
2021-02-28$6.77/sh+21,096$142,820→ 91,096 totalExercise: $6.77Exp: 2031-02-28→ Common Stock (21,096 underlying)
Footnotes (2)
- [F1]The option was granted on February 26, 2021. The shares underlying the option are scheduled to vest in four equal annual installments, with the first such installment occurring on February 26, 2022.
- [F2]The option was granted on February 28, 2021 and represents a pro rata amount of the annual 25,000 option board grant based on the number of days this year the reporting person is anticipated to serve as a director. The shares underlying the option are scheduled to vest in full on December 31, 2021.